Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

novigenix colox clinical cancer research

News and Trends 9 May 2016

Swiss Blood Test for colorectal cancer joins race of ‘Liquid Biopsies’

Novigenix has published a validation study of its molecular blood test (Colox) which can reliably detect colorectal cancer at an early stage. Is this the second-place diagnostic in the race for Colorectal cancer blood tests? Based in Lausanne (Switzerland), Novigenix is developing molecular diagnostics from a new generation of predictive gene expression profiles and tumor-derived protein markers (biomarkers). Novigenix first […]

May 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

3786796086 60a926fc79 o

News and Trends 9 May 2016

Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure

Update (09/05/2017): AiCuris has started a Phase II trial, PRIOH-1, with the oral version of its herpes cure pritelivir. Update (17/01/2017): The company has presented results from its first Phase II trial with pritelivir. The drug candidate proved to work better than the antiviral drug valacyclovir, currently the standard of care. Update (01/12/2017): AiCuris announced […]

May 9, 2016 - 2 minutesmins - By Evelyn Warner

allergy therapeutics birch pollen rhinitis biotech uk

News and Trends 9 May 2016

UK Biopharma joins Allergy race with good Phase II results for Hayfever

Allergy Therapeutics has gotten positive results for its phase II trial for birch pollen allergy – another win for their Pollinex platform. Based near Brighton (UK), Allergy Therapeutics has around 420 employees and has a market cap of €1.96M (£1.53M). Its focus is novel immunotherapies, with new technology for improving delivery and adjuvants – agents […]

May 9, 2016 - 2 minutesmins - By Denise Neves Gameiro

cellectis cancer leukemia ucart19 car t cell therapy GOSH baby second biotech

News and Trends 9 May 2016

Universal CAR-T given to Second baby with aggressive Leukemia

Once again, the French biotech Cellectis has hit headlines after having treated a second infant suffering from an aggressive form of Leukemia with their UCART19 therapy. Also based at the famous Great Ormond Street Hospital (GOSH) in London, another child has been treated with the first ever Universal CAR-T cell therapy. The child in question […]

May 9, 2016 - 2 minutesmins - By Dani Bancroft

landscape pixabay biotech

News and Trends 7 May 2016

What happened this week? Copenhagen Biotechs, Bio-lighting, China

1. Here are 12 Biotechs you need to know in Copenhagen – Skål! 2. ‘First Blood Test for Colorectal Cancer is One of the most Innovative Medical Products’ says Chinese FDA 3. Feel like investing in Bio-Lighting? Here’s your chance 4. What’s the Vatican doing with Biotech? Awarding Billionaire Doctors for Cancer & Stem Cell Research 5. Genetic Diagnostic […]

May 7, 2016 - 1 minutemin - By Philip Hemme

bioart zim zou lucie thibault nancy

News and Trends 7 May 2016

BioArt: Vibrant Paper Vaccines, Vitamins and Controversial Farming

Zim & Zou are a French duo making colourful 3D models. Their vibrant art raises awareness of the food industry, healthy eating and children’s vaccination. Zim & Zou is the graphic design studio of Thibaut Zimmerman and Lucie Thomas, based in Nancy (France). After studying design, the two 28-year olds moved away from digital work to focus on tangible installations […]

May 7, 2016 - 3 minutesmins - By Denise Neves Gameiro

ADVERTISEMENT

mit uniqure glybera lipoprotein lipase

News and Trends 6 May 2016

This Dutch Gene Therapy is on the shelf and seems to Work. But nobody is buying…

uniQure‘s Glybera was approved in Europe in 2012, making it the first gene therapy on the market in the West. But so far this €1M therapy has only been bought once… The approval of Glybera was an important milestone for Biotech. After years of being deemed too risky (after the death of Jesse Gelsinger in 1999), a […]

May 6, 2016 - 3 minutesmins - By Denise Neves Gameiro

affibody stockholm biotech week header

News and Trends 6 May 2016

Biotech of the Week: Affibody and its Super antibodies from Scandinavia

From North Israel, we once again depart North towards Scandinavia to visit Sweden. On one of the several islands that make Stockholm a very particular and special European capital, our Biotech of the week Affibody has its headquarters. City: Stockholm (Sweden) – (actually just down the road from the Karolinska Institute) Founded: 1998 Employees: 22 (as of 11/2015) […]

May 6, 2016 - 2 minutesmins - By Joachim Eeckhout

orchard f prime ucl hematopoietic gene therapy

News and Trends 6 May 2016

Stem cell Biotech gets €26M to Start-off Gene Therapy Development for Children

Orchard Therapeutics has just been launched with a €26M investment led by a major investor. It will be developing gene therapies for a range of blood-related disorders in children. Based in London, Orchard Therapeutics may have just been founded, but it’s based on a long scientific track record. Its founding scientists have been pioneering the area […]

May 6, 2016 - 3 minutesmins - By Denise Neves Gameiro

coverNeovac JeanSibilia MiguelSieler

News and Trends 6 May 2016

Interview with Two Key People of the Fight Against Lupus

I was in Paris this week in the building of the Rare Disease Alliance, an association helping patients affected by a rare disease. The association lend their space to Neovacs, a biotech company from Paris, which was organising a gathering of experts of lupus. Lupus is one of the most common rare disease and affects more than 5 million […]

May 6, 2016 - 1 minutemin - By Joachim Eeckhout

manchester biotechnology biobased propane cyanobacteria

News and Trends 4 May 2016

How the UK is Engineering Bacteria to produce Propane for Greener Fuels

Researchers from the Manchester Institute of Biotechnology are working in engineering a microbe capable of producing propane – an increasingly important fuel. Propane is an emerging fuel, used from heating to transport fuel. Therefore, producing it via synthetic biology has been a major target in the biofuel field to be Greener. This is especially because biobased propane it’s a […]

May 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

Epigenomics cancer colorectal china CFDA beijing biochain diagnostic blood test epiprocolon septin9

News and Trends 4 May 2016

‘First Blood Test for Colorectal Cancer is One of the most Innovative Medical Products’ says Chinese FDA

That’s what the China Food and Drug Administration (CFDA) declared on the blood diagnostic test from Berlin-based Epigenomics‘ proprietary Septin9-Biomarker. Their Septin9 test Epi proColon is filling the need for early detection of colorectal cancer. Data show a huge increase in prevalence in urban China.Just last week we interviewed the CEO of Epigenomics, Thomas Taapken, on the company’s Cancer […]

May 4, 2016 - 3 minutesmins - By Dani Bancroft

ADVERTISEMENT